Paperpal Prime Logo

Metas de Enfermeria : Impact Factor & More

pISSN: 1138-7262

Key Metrics

SJR
Q4Nursing (all)
Recommended pre-submission checks
Powered by Paperpal by Editage

Metas de Enfermeria Journal Specifications

Indexed in the following public directories

  • Scopus Scopus
  • SJR SJR
Overview
Publisher DAE Editorial, Grupo Paradigma

Planning to publish in Metas de Enfermeria ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Metas de Enfermeria

Artificial and Other Non-Nutritive Sweeteners, the Microbiome, and Cardiometabolic Health.
  • 25 Jun 2026
  • Current atherosclerosis reports
Single-cell Technologies in Atherosclerosis: Uncovering Cellular Heterogeneity, Mechanisms, and Therapeutic Opportunities.
  • 18 Jun 2026
  • Current atherosclerosis reports
Comparative Efficacy of Nutraceuticals on Endothelial Function: A Systematic Review and Network Meta-Analysis.
  • 12 Jun 2026
  • Current atherosclerosis reports
Familial Hypercholesterolemia in Women: Diagnosis, Treatment, and Cardiovascular Outcomes Across the Lifespan.
  • 8 Jun 2026
  • Current atherosclerosis reports
Micro-and Nano-Plastic Exposure as an Emerging Risk for Atherosclerotic Cardiovascular Disease.
  • 5 Jun 2026
  • Current atherosclerosis reports
Old and New Lines of Therapy Targeting Lipoprotein(a).
  • 3 Jun 2026
  • Current atherosclerosis reports
Artificial and Other Non-Nutritive Sweeteners, the Microbiome, and Cardiometabolic Health.
  • 25 Jun 2026
  • Current atherosclerosis reports
Single-cell Technologies in Atherosclerosis: Uncovering Cellular Heterogeneity, Mechanisms, and Therapeutic Opportunities.
  • 18 Jun 2026
  • Current atherosclerosis reports
Comparative Efficacy of Nutraceuticals on Endothelial Function: A Systematic Review and Network Meta-Analysis.
  • 12 Jun 2026
  • Current atherosclerosis reports
Familial Hypercholesterolemia in Women: Diagnosis, Treatment, and Cardiovascular Outcomes Across the Lifespan.
  • 8 Jun 2026
  • Current atherosclerosis reports
Micro-and Nano-Plastic Exposure as an Emerging Risk for Atherosclerotic Cardiovascular Disease.
  • 5 Jun 2026
  • Current atherosclerosis reports
Old and New Lines of Therapy Targeting Lipoprotein(a).
  • 3 Jun 2026
  • Current atherosclerosis reports

FAQs on Metas de Enfermeria